{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T12:11:38Z","timestamp":1775909498594,"version":"3.50.1"},"reference-count":34,"publisher":"Japanese Circulation Society","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2010]]},"DOI":"10.1253\/circj.cj-09-0880","type":"journal-article","created":{"date-parts":[[2010,3,25]],"date-time":"2010-03-25T06:08:10Z","timestamp":1269497290000},"page":"701-708","source":"Crossref","is-referenced-by-count":80,"title":["Comparison of Different Antithrombotic Regimens for Patients With Atrial Fibrillation Undergoing Drug-Eluting Stent Implantation"],"prefix":"10.1253","volume":"74","author":[{"given":"Fei","family":"Gao","sequence":"first","affiliation":[{"name":"Department of Cardiology, An Zhen Hospital, Capital Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu Jie","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Cardiology, An Zhen Hospital, Capital Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi Jian","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, An Zhen Hospital, Capital Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Shen","sequence":"additional","affiliation":[{"name":"Department of Cardiology, An Zhen Hospital, Capital Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao Li","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, An Zhen Hospital, Capital Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Nie","sequence":"additional","affiliation":[{"name":"Department of Cardiology, An Zhen Hospital, Capital Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen Xian","family":"Yan","sequence":"additional","affiliation":[{"name":"Department of Cardiology, An Zhen Hospital, Capital Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shi Wei","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, An Zhen Hospital, Capital Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"De An","family":"Jia","sequence":"additional","affiliation":[{"name":"Department of Cardiology, An Zhen Hospital, Capital Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miao","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, An Zhen Hospital, Capital Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2007.10.002"},{"key":"2","unstructured":"2. Fuster V, Rydén LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, et al. ACC\/AHA\/ESC 2006 guidelines for the management of patients with atrial fibrillation. Executive summary: A report of the American College of Cardiology\/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation). Eur Heart J 2006; 27: 1979-2030."},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Lip GY, Huber K, Andreotti F, Arnesen H, Airaksinen J, Cuisset T, et al. Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and\/or undergoing percutaneous coronary intervention\/stenting. Thromb Haemost 2010; 103: 13-28.","DOI":"10.1160\/TH09-08-0580"},{"key":"4","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehl488"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Orford JL, Fasseas P, Melby S, Burger K, Steinhubl SR, Holmes DR, et al. Safety and efficacy of aspirin, clopidogrel, and warfarin after coronary stent placement in patients with an indication for anticoagulation. Am Heart J 2004; 147: 463-467.","DOI":"10.1016\/j.ahj.2003.06.004"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Manzano-Fernández S, Pastor FJ, Marín F, Cambronero F, Caro C, Pascual-Figal DA, et al. Increased major bleeding complications related to triple antithrombotic therapy usage in patients with atrial fibrillation undergoing percutaneous coronary artery stenting. Chest 2008; 134: 559-567.","DOI":"10.1378\/chest.08-0350"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Konstantino Y, Iakobishvili Z, Porter A, Sandach A, Zahger D, Hod H, et al. Aspirin, warfarin and a thienopyridine for acute coronary syndromes. Cardiology 2006; 105: 80-85.","DOI":"10.1159\/000089548"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. DeEugenio D, Kolman L, DeCaro M, Andrel J, Chervoneva I, Duong P, et al. Risk of major bleeding with concomitant dual antiplatelet therapy after percutaneous coronary intervention in patients receiving long-term warfarin therapy. Pharmacotherapy 2007; 27: 691-696.","DOI":"10.1592\/phco.27.5.691"},{"key":"9","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)68845-4"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Apostolakis S, Shantsila E, Lip GY, Lane DA. Contra: \"Anti-platelet therapy is an alternative to oral anticoagulation for atrial fibrillation\". Thromb Haemost 2009; 102: 914-915.","DOI":"10.1160\/TH09-08-0563"},{"key":"11","doi-asserted-by":"publisher","DOI":"10.1001\/jama.285.22.2864"},{"key":"12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa067731"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Rao AK, Pratt C, Berke A, Jaffe A, Ockene I, Schreiber TL, et al. Thrombolysis In Myocardial Infarction (TIMI) Trial. Phase I: Hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase. J Am Coll Cardiol 1988; 11: 1-11.","DOI":"10.1016\/0735-1097(88)90158-1"},{"key":"14","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2006040368"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Rubboli A, Milandri M, Castelvetri C, Cosmi B. Meta-analysis of trials comparing oral anticoagulation and aspirin versus dual antiplatelet therapy after coronary stenting: Clues for the management of patients with an indication for long-term anticoagulation undergoing coronary stenting. Cardiology 2005; 104: 101-106.","DOI":"10.1159\/000086918"},{"key":"16","unstructured":"16. Khurram Z, Chou E, Minutello R, Bergman G, Parikh M, Naidu S, et al. Combination therapy with aspirin, clopidogrel and warfarin following coronary stenting is associated with a significant risk of bleeding. J Invasive Cardiol 2006; 18: 162-164."},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Rossini R, Musumeci G, Lettieri C, Molfese M, Mihalcsik L, Mantovani P, et al. Long-term outcomes in patients undergoing coronary stenting on dual oral antiplatelet treatment requiring oral anticoagulant therapy. Am J Cardiol 2008; 102: 1618-1623.","DOI":"10.1016\/j.amjcard.2008.08.021"},{"key":"18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2007.11.035"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Shen AY, Yao JF, Brar SS, Jorgensen MB, Wang X, Chen W. Racial\/ethnic differences in ischemic stroke rates and the efficacy of warfarin among patients with atrial fibrillation. Stroke 2008; 39: 2736-2743.","DOI":"10.1161\/STROKEAHA.107.508580"},{"key":"20","unstructured":"20. Nguyen MC, Lim YL, Walton A, Lefkovits J, Agnelli G, Goodman SG, et al. GRACE Investigators. Combining warfarin and antiplatelet therapy after coronary stenting in the Global Registry of Acute Coronary Events: Is it safe and effective to use just one antiplatelet agent? Eur Heart J 2007; 28: 1717-1722."},{"key":"21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2006.10.026"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Brar SS, Kim J, Brar SK, Zadegan R, Ree M, Liu IL, et al. Long-term outcomes by clopidogrel duration and stent type in a diabetic population with de novo coronary artery lesions. J Am Coll Cardiol 2008; 51: 2220-2227.","DOI":"10.1016\/j.jacc.2008.01.063"},{"key":"23","doi-asserted-by":"publisher","DOI":"10.1001\/jama.297.2.joc60179"},{"key":"24","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa067484"},{"key":"25","doi-asserted-by":"publisher","DOI":"10.1253\/circj.CJ-08-0851"},{"key":"26","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa066633"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Inoue T, Node K. Molecular basis of restenosis and novel issues of drug-eluting stents. Circ J 2009; 73: 615-621.","DOI":"10.1253\/circj.CJ-09-0059"},{"key":"28","doi-asserted-by":"publisher","DOI":"10.1253\/circj.CJ-09-0377"},{"key":"29","doi-asserted-by":"publisher","DOI":"10.1253\/circj.CJ-08-1116"},{"key":"30","doi-asserted-by":"publisher","DOI":"10.1253\/circj.72.1201"},{"key":"31","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)60314-6"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Gilard M, Blanchard D, Helft G, Carrier D, Eltchaninoff H, Belle L, et al. STENTICO Investigators. Antiplatelet therapy in patients with anticoagulants undergoing percutaneous coronary stenting (from STENTIng and oral antiCOagulants [STENTICO]). Am J Cardiol 2009; 104: 338-342.","DOI":"10.1016\/j.amjcard.2009.03.053"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Zahger D, Ilia R. Coronary stenting in warfarin treated patients. EuroIntervention 2009; 5: 277-281.","DOI":"10.4244\/EIJV5I2A43"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Holmes DR Jr, Kereiakes DJ, Kleiman NS, Moliterno DJ, Patti G, Grines CL. Combining antiplatelet and anticoagulant therapies. J Am Coll Cardiol 2009; 54: 95-109.","DOI":"10.1016\/j.jacc.2009.03.044"}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/circj\/74\/4\/74_CJ-09-0880\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,25]],"date-time":"2021-03-25T03:52:08Z","timestamp":1616644328000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/circj\/74\/4\/74_CJ-09-0880\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-09-0880","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"value":"1346-9843","type":"print"},{"value":"1347-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010]]}}}